HY-108507-1mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-100mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-25mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-5mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-50mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-130767A-100mg
|
MedChemexpress LLC
|
Naphthol AS-TR phosphate (disodium) [CAS 4264-93-1]
|
|
|
|
HY-P2185A-1mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-P2185A-10mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-P2185A-5mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-18166-10mg
|
MedChemexpress LLC
|
NIBR0213 [CAS 1233332-14-3]
|
|
COVID-19-immunoregulation
|
|
HY-18166-100mg
|
MedChemexpress LLC
|
NIBR0213 [CAS 1233332-14-3]
|
|
COVID-19-immunoregulation
|
|
HY-18166-25mg
|
MedChemexpress LLC
|
NIBR0213 [CAS 1233332-14-3]
|
|
COVID-19-immunoregulation
|
|
HY-18166-5mg
|
MedChemexpress LLC
|
NIBR0213 [CAS 1233332-14-3]
|
|
COVID-19-immunoregulation
|
|
HY-18166-50mg
|
MedChemexpress LLC
|
NIBR0213 [CAS 1233332-14-3]
|
|
COVID-19-immunoregulation
|
|